Intravenous	intravenous	O	O
administration	administration	O	O
of	of	O	O
prochlorperazine	prochlorperazine	O	O
by	by	O	O
15-minute	15-minute	O	O
infusion	infusion	O	O
versus	versus	O	O
2-minute	2-minute	O	O
bolus	bolus	O	O
does	does	O	O
not	not	O	O
affect	affect	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
akathisia	akathisia	O	S_disease
:	:	O	O
a	a	O	O
prospective	prospective	O	O
,	,	O	O
randomized	randomized	O	O
,	,	O	O
controlled	controlled	O	O
trial	trial	O	O
.	.	O	O

STUDY	study	O	O
OBJECTIVE	objective	O	O
:	:	O	O
We	we	O	O
sought	sought	O	O
to	to	O	O
compare	compare	O	O
the	the	O	O
rate	rate	O	O
of	of	O	O
akathisia	akathisia	O	S_disease
after	after	O	O
administration	administration	O	O
of	of	O	O
intravenous	intravenous	O	O
prochlorperazine	prochlorperazine	O	O
as	as	O	O
a	a	O	O
2-minute	2-minute	O	O
bolus	bolus	O	O
or	or	O	O
15-minute	15-minute	O	O
infusion	infusion	O	O
.	.	O	O

METHODS	methods	O	O
:	:	O	O
We	we	O	O
conducted	conducted	O	O
a	a	O	O
prospective	prospective	O	O
,	,	O	O
randomized	randomized	O	O
,	,	O	O
double-blind	double-blind	O	O
study	study	O	O
in	in	O	O
the	the	O	O
emergency	emergency	O	S_disease
department	department	O	O
of	of	O	O
a	a	O	O
central-city	central-city	O	O
teaching	teaching	O	O
hospital	hospital	O	O
.	.	O	O

Patients	patients	O	O
aged	aged	O	O
18	18	O	O
years	years	O	O
or	or	O	O
older	older	O	O
treated	treated	O	O
with	with	O	O
prochlorperazine	prochlorperazine	O	O
for	for	O	O
headache	headache	O	S_disease
,	,	O	O
nausea	nausea	O	O
,	,	O	O
or	or	O	O
vomiting	vomiting	O	S_disease
were	were	O	O
eligible	eligible	O	O
for	for	O	O
inclusion	inclusion	O	O
.	.	O	O

Study	study	O	O
participants	participants	O	O
were	were	O	O
randomized	randomized	O	O
to	to	O	O
receive	receive	O	O
10	10	O	O
mg	mg	O	O
of	of	O	O
prochlorperazine	prochlorperazine	O	O
administered	administered	O	O
intravenously	intravenously	O	O
by	by	O	O
means	means	O	O
of	of	O	O
2-minute	2-minute	O	O
push	push	O	O
(	(	O	O
bolus	bolus	O	O
group	group	O	O
)	)	O	O
or	or	O	O
10	10	O	O
mg	mg	O	O
diluted	diluted	O	O
in	in	O	O
50	50	O	O
mL	ml	O	O
of	of	O	O
normal	normal	B_chemicals	O
saline	saline	B_chemicals	O
solution	solution	S_chemicals	O
administered	administered	O	O
by	by	O	O
means	means	O	O
of	of	O	O
intravenous	intravenous	O	O
infusion	infusion	O	O
during	during	O	O
a	a	O	O
15-minute	15-minute	O	O
period	period	O	O
(	(	O	O
infusion	infusion	O	O
group	group	O	O
)	)	O	O
.	.	O	O

The	the	O	O
main	main	O	O
outcome	outcome	O	O
was	was	O	O
the	the	O	O
number	number	O	O
of	of	O	O
study	study	O	O
participants	participants	O	O
experiencing	experiencing	O	O
akathisia	akathisia	O	S_disease
within	within	O	O
60	60	O	O
minutes	minutes	O	O
of	of	O	O
administration	administration	O	O
.	.	O	O

Akathisia	akathisia	O	S_disease
was	was	O	O
defined	defined	O	O
as	as	O	O
either	either	O	O
a	a	O	O
spontaneous	spontaneous	O	O
report	report	O	O
of	of	O	O
restlessness	restlessness	O	S_disease
or	or	O	O
agitation	agitation	O	O
or	or	O	O
a	a	O	O
change	change	O	O
of	of	O	O
2	2	O	O
or	or	O	O
more	more	O	O
in	in	O	O
the	the	O	O
patient-reported	patient-reported	O	O
akathisia	akathisia	O	S_disease
rating	rating	O	O
scale	scale	O	O
and	and	O	O
a	a	O	O
change	change	O	O
of	of	O	O
at	at	O	O
least	least	O	O
1	1	O	O
in	in	O	O
the	the	O	O
investigator-observed	investigator-observed	O	O
akathisia	akathisia	O	S_disease
rating	rating	O	O
scale	scale	O	O
.	.	O	O

The	the	O	O
intensity	intensity	O	O
of	of	O	O
headache	headache	O	S_disease
and	and	O	O
nausea	nausea	O	O
was	was	O	O
measured	measured	O	O
with	with	O	O
a	a	O	O
100-mm	100-mm	O	O
visual	visual	O	O
analog	analog	S_chemicals	O
scale	scale	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
One	one	O	O
hundred	hundred	O	O
patients	patients	O	O
were	were	O	O
enrolled	enrolled	O	O
.	.	O	O

One	one	O	O
study	study	O	O
participant	participant	O	O
was	was	O	O
excluded	excluded	O	O
after	after	O	O
protocol	protocol	O	O
violation	violation	O	O
.	.	O	O

Seventy-three	seventy-three	O	O
percent	percent	O	O
(	(	O	O
73/99	73/99	O	O
)	)	O	O
of	of	O	O
the	the	O	O
study	study	O	O
participants	participants	O	O
were	were	O	O
treated	treated	O	O
for	for	O	O
headache	headache	O	S_disease
and	and	O	O
70	70	O	O
%	%	O	O
(	(	O	O
70/99	70/99	O	O
)	)	O	O
for	for	O	O
nausea	nausea	O	O
.	.	O	O

In	in	O	O
the	the	O	O
bolus	bolus	O	O
group	group	O	O
,	,	O	O
26.0	26.0	O	O
%	%	O	O
(	(	O	O
13/50	13/50	O	O
)	)	O	O
had	had	O	O
akathisia	akathisia	O	S_disease
compared	compared	O	O
with	with	O	O
32.7	32.7	O	O
%	%	O	O
(	(	O	O
16/49	16/49	O	O
)	)	O	O
in	in	O	O
the	the	O	O
infusion	infusion	O	O
group	group	O	O
(	(	O	O
Delta=-6.7	delta=-6.7	O	O
%	%	O	O
;	;	O	O
95	95	O	O
%	%	O	O
confidence	confidence	O	O
interval	interval	O	O
[	[	O	O
CI	ci	O	O
]	]	O	O
-24.6	-24.6	O	O
%	%	O	O
to	to	O	O
11.2	11.2	O	O
%	%	O	O
)	)	O	O
.	.	O	O

The	the	O	O
difference	difference	O	O
between	between	O	O
the	the	O	O
bolus	bolus	O	O
and	and	O	O
infusion	infusion	O	O
groups	groups	O	O
in	in	O	O
the	the	O	O
percentage	percentage	O	O
of	of	O	O
participants	participants	O	O
who	who	O	O
saw	saw	O	O
a	a	O	O
50	50	O	O
%	%	O	O
reduction	reduction	O	O
in	in	O	O
their	their	O	O
headache	headache	O	S_disease
intensity	intensity	O	O
within	within	O	O
30	30	O	O
minutes	minutes	O	O
was	was	O	O
11.8	11.8	O	O
%	%	O	O
(	(	O	O
95	95	O	O
%	%	O	O
CI	ci	O	O
-9.6	-9.6	O	O
%	%	O	O
to	to	O	O
33.3	33.3	O	O
%	%	O	O
)	)	O	O
.	.	O	O

The	the	O	O
difference	difference	O	O
in	in	O	O
the	the	O	O
percentage	percentage	O	O
of	of	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
50	50	O	O
%	%	O	O
reduction	reduction	O	O
in	in	O	O
their	their	O	O
nausea	nausea	O	O
was	was	O	O
12.6	12.6	O	O
%	%	O	O
(	(	O	O
95	95	O	O
%	%	O	O
CI	ci	O	O
-4.6	-4.6	O	O
%	%	O	O
to	to	O	O
29.8	29.8	O	O
%	%	O	O
)	)	O	O
.	.	O	O

CONCLUSION	conclusion	O	O
:	:	O	O
A	a	O	O
50	50	O	O
%	%	O	O
reduction	reduction	O	O
in	in	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
akathisia	akathisia	O	S_disease
when	when	O	O
prochlorperazine	prochlorperazine	O	O
was	was	O	O
administered	administered	O	O
by	by	O	O
means	means	O	O
of	of	O	O
15-minute	15-minute	O	O
intravenous	intravenous	O	O
infusion	infusion	O	O
versus	versus	O	O
a	a	O	O
2-minute	2-minute	O	O
intravenous	intravenous	O	O
push	push	O	O
was	was	O	O
not	not	O	O
detected	detected	O	O
.	.	O	O

The	the	O	O
efficacy	efficacy	O	O
of	of	O	O
prochlorperazine	prochlorperazine	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
headache	headache	O	S_disease
and	and	O	O
nausea	nausea	O	O
likewise	likewise	O	O
did	did	O	O
not	not	O	O
appear	appear	O	O
to	to	O	O
be	be	O	O
affected	affected	O	O
by	by	O	O
the	the	O	O
rate	rate	O	O
of	of	O	O
administration	administration	O	O
,	,	O	O
although	although	O	O
no	no	O	O
formal	formal	O	O
statistical	statistical	O	O
comparisons	comparisons	O	O
were	were	O	O
made	made	O	O
.	.	O	O

